265 related articles for article (PubMed ID: 25652746)
41. Prevalence and circulation patterns of variant, atypical and resistant HIV in Los Angeles County (2007-2009).
Sey K; Ma Y; Lan YC; Song N; Hu YW; Ou Y; Frye D
J Med Virol; 2014 Oct; 86(10):1639-47. PubMed ID: 24976142
[TBL] [Abstract][Full Text] [Related]
42. Assessing transmissibility of HIV-1 drug resistance mutations from treated and from drug-naive individuals.
Winand R; Theys K; Eusébio M; Aerts J; Camacho RJ; Gomes P; Suchard MA; Vandamme AM; Abecasis AB;
AIDS; 2015 Sep; 29(15):2045-52. PubMed ID: 26355575
[TBL] [Abstract][Full Text] [Related]
43. Molecular characterization of HIV type 1 strains from newly diagnosed patients in Cyprus (2007-2009) recovers multiple clades including unique recombinant strains and lack of transmitted drug resistance.
Kousiappa I; Achilleos C; Hezka J; Lazarou Y; Othonos K; Demetriades I; Kostrikis LG
AIDS Res Hum Retroviruses; 2011 Nov; 27(11):1183-99. PubMed ID: 21453134
[TBL] [Abstract][Full Text] [Related]
44. Analysis of the diversity of the HIV-1 pol gene and drug resistance associated changes among drug-naïve patients in Burkina Faso.
Tebit DM; Sangaré L; Tiba F; Saydou Y; Makamtse A; Somlare H; Bado G; Kouldiaty BG; Zabsonre I; Yameogo SL; Sathiandee K; Drabo JY; Kräusslich HG
J Med Virol; 2009 Oct; 81(10):1691-701. PubMed ID: 19697403
[TBL] [Abstract][Full Text] [Related]
45. The molecular epidemiology and drug resistance determination of HIV type 1 subtype B infection in Barbados.
Gittens MV; Roth WW; Roach T; Stringer HG; Pieniazek D; Bond VC; Levett PN
AIDS Res Hum Retroviruses; 2003 Apr; 19(4):313-9. PubMed ID: 12816080
[TBL] [Abstract][Full Text] [Related]
46. High HIV-1 Diversity and Prevalence of Transmitted Drug Resistance Among Antiretroviral-Naive HIV-Infected Pregnant Women from Rio de Janeiro, Brazil.
Delatorre E; Silva-de-Jesus C; Couto-Fernandez JC; Pilotto JH; Morgado MG
AIDS Res Hum Retroviruses; 2017 Jan; 33(1):68-73. PubMed ID: 27392995
[TBL] [Abstract][Full Text] [Related]
47. Diversity of human immunodeficiency virus type 1 subtype A and CRF03_AB protease in Eastern Europe: selection of the V77I variant and its rapid spread in injecting drug user populations.
Roudinskii NI; Sukhanova AL; Kazennova EV; Weber JN; Pokrovsky VV; Mikhailovich VM; Bobkov AF
J Virol; 2004 Oct; 78(20):11276-87. PubMed ID: 15452247
[TBL] [Abstract][Full Text] [Related]
48. HIV-1 Genetic Diversity and Transmitted Drug Resistance in Antiretroviral Treatment-Naive Individuals from Amapá State, Northern Brazil.
Dos Anjos Silva L; Divino F; da Silva Rêgo MO; Lima Lopes IG; Nóbrega Costa CM; da Silva Pereira FC; de Filippis I; Bello G
AIDS Res Hum Retroviruses; 2016 Apr; 32(4):373-6. PubMed ID: 26529282
[TBL] [Abstract][Full Text] [Related]
49. High incidence of non-B and recombinant HIV-1 strains in newly diagnosed patients in Galicia, Spain: study of genotypic resistance.
Pérez-Alvarez L; Carmona R; Muñoz M; Delgado E; Thomson MM; Contreras G; Pedreira JD; Rodríguez Real R; Vázquez de Parga E; Medrano L; Taboada JA; Nájera R;
Antivir Ther; 2003 Aug; 8(4):355-60. PubMed ID: 14518705
[TBL] [Abstract][Full Text] [Related]
50. HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations.
Aulicino PC; Rocco CA; Mecikovsky D; Bologna R; Mangano A; Sen L
Antivir Ther; 2010; 15(4):641-50. PubMed ID: 20587857
[TBL] [Abstract][Full Text] [Related]
51. Transmitted drug-resistance in human immunodeficiency virus-infected adult population in El Salvador, Central America.
Holguín Á; Yebra G; Martín L; de Pineda AT; Ruiz LE; Quezada AY; Nieto AI; Escobar G
Clin Microbiol Infect; 2013 Dec; 19(12):E523-32. PubMed ID: 23782115
[TBL] [Abstract][Full Text] [Related]
52. Phylogenetic diversity and low level antiretroviral resistance mutations in HIV type 1 treatment-naive patients from Cape Town, South Africa.
Jacobs GB; Laten A; van Rensburg EJ; Bodem J; Weissbrich B; Rethwilm A; Preiser W; Engelbrecht S
AIDS Res Hum Retroviruses; 2008 Jul; 24(7):1009-12. PubMed ID: 18593350
[TBL] [Abstract][Full Text] [Related]
53. Geographic and temporal trends of transmitted HIV-1 drug resistance among antiretroviral-naïve subjects screening for two clinical trials in North America and Western Europe.
Rahim S; Fredrick LM; da Silva BA; Bernstein B; King MS
HIV Clin Trials; 2009; 10(2):94-103. PubMed ID: 19487179
[TBL] [Abstract][Full Text] [Related]
54. Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia.
Balode D; Westman M; Kolupajeva T; Rozentale B; Albert J
J Med Virol; 2010 Dec; 82(12):2013-8. PubMed ID: 20981787
[TBL] [Abstract][Full Text] [Related]
55. Subtype assignment and phylogenetic analysis of HIV type 1 strains in patients from Swaziland.
Dehò L; Walwema R; Cappelletti A; Sukati H; Sibandze D; Almaviva M; Buttò S; Ensoli B; Galli M; Balotta C
AIDS Res Hum Retroviruses; 2008 Feb; 24(2):323-5. PubMed ID: 18257688
[TBL] [Abstract][Full Text] [Related]
56. Longitudinal Trends in Western Australian HIV-1 Sequence Diversity and Viral Transmission Networks and Their Influence on Clinical Parameters: 2000-2014.
Castley AS; Gaudieri S; James I; Gizzarelli LS; Guelfi G; John M; Nolan D
AIDS Res Hum Retroviruses; 2016 Mar; 32(3):211-9. PubMed ID: 26530340
[TBL] [Abstract][Full Text] [Related]
57. Surveillance of HIV type 1 drug resistance among naive patients from Venezuela.
Castillo J; Comegna M; Quijada W; Jauvin V; Pinson P; Masquelier B; Fleury H; Castro E
AIDS Res Hum Retroviruses; 2009 Dec; 25(12):1329-33. PubMed ID: 19954301
[TBL] [Abstract][Full Text] [Related]
58. Appearance of drug resistance-associated mutations in human immunodeficiency virus type 1 protease and reverse transcriptase derived from drug-treated Indonesian patients.
Khairunisa SQ; Kotaki T; Witaningrum AM; Yunifiar M MQ; Sukartiningrum SD; Nasronudin ; Kameoka M
AIDS Res Hum Retroviruses; 2015 Feb; 31(2):255-9. PubMed ID: 25348045
[TBL] [Abstract][Full Text] [Related]
59. Co-circulation HIV-1 subtypes B, C, and CRF31_BC in a drug-naïve population from Southernmost Brazil: analysis of primary resistance mutations.
de Medeiros RM; Junqueira DM; Matte MC; Barcellos NT; Chies JA; Matos Almeida SE
J Med Virol; 2011 Oct; 83(10):1682-8. PubMed ID: 21837783
[TBL] [Abstract][Full Text] [Related]
60. Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France.
Descamps D; Chaix ML; Montes B; Pakianather S; Charpentier C; Storto A; Barin F; Dos Santos G; Krivine A; Delaugerre C; Izopet J; Marcelin AG; Maillard A; Morand-Joubert L; Pallier C; Plantier JC; Tamalet C; Cottalorda J; Desbois D; Calvez V; Brun-Vezinet F; Masquelier B; Costagliola D;
J Antimicrob Chemother; 2010 Dec; 65(12):2620-7. PubMed ID: 20965891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
